Selasa, 21 April 2015

Free PDF Magic Cancer Bullet: How a Tiny Orange Pill May Rewrite Medical History

Free PDF Magic Cancer Bullet: How a Tiny Orange Pill May Rewrite Medical History

Magic Cancer Bullet: How A Tiny Orange Pill May Rewrite Medical History is a sort of publication with extremely fantastic concepts to understand. Exactly how the writer begin to motivate you, exactly how the author get the ideas to create as this book, as well as exactly how the author has an amazing minds that give you this fantastic simple book to review. As we stated previously, the Magic Cancer Bullet: How A Tiny Orange Pill May Rewrite Medical History truly includes something devoted. If you have such suitable and also objective to actually reach, this publication can be the assistance to overcome it. You may not only get the knowledge pertaining to your job or obligations now. You will certainly get more points.

Magic Cancer Bullet: How a Tiny Orange Pill May Rewrite Medical History

Magic Cancer Bullet: How a Tiny Orange Pill May Rewrite Medical History


Magic Cancer Bullet: How a Tiny Orange Pill May Rewrite Medical History


Free PDF Magic Cancer Bullet: How a Tiny Orange Pill May Rewrite Medical History

Do you require new recommendation to accompany your leisure when going to residence? Checking out a book can be a great selection. It could save your time usefully. Besides, by reading publication, you can enhance your expertise and also experience. It is not only the scientific research or social expertise; many things can be acquired after checking out a book.

And also to advise you a much better book with great top quality, you could pick Magic Cancer Bullet: How A Tiny Orange Pill May Rewrite Medical History Why we refer this publication for you? We understand that you are currently searching for the qualified book pertaining to this topic. For this reason, you could begin it by getting this book as one of the selected reading book. It is not about guide that is composed by a really professional author or released by incredibly popular author. This has to do with the book that is preferred one as well as impact for your needs.

Well, in order to supply the best publication advised, we lead you to get the link. This site always displays the web link that is satisfied the book that is extended. As well as this time, Magic Cancer Bullet: How A Tiny Orange Pill May Rewrite Medical History in soft file system is coming. This coming publication is additionally provided in soft file. So, you can establish it securely in the devices. If you typically locate the printed publication to review, now you could locate the book in soft data.

It is not just to offer you the simple way however also to get the book is soft data systems. This is the reason why you could get the book asap. By connecting to internet, your possibility to locate as well as obtain the Magic Cancer Bullet: How A Tiny Orange Pill May Rewrite Medical History immediately. By clicking link that is proffered in this site, you can go to directly guide website. As well as, that's your time to get your much-loved publication.

Magic Cancer Bullet: How a Tiny Orange Pill May Rewrite Medical History

From Publishers Weekly

Gleevec is one of the few cancer drugs hailed as a breakthrough that, so far, has largely lived up to its hype. Vasella, the CEO and chairman of pharmaceutical giant Novartis (which manufactures Gleevec), and Slater (Jack Welch & the GE Way) outline the development, remarkably successful clinical trials and accelerated production and approval process that led to the drug's speedy entry onto the market for the treatment of a rare cancer known as chronic myeloid leukemia (CML). Although the story's components-devoted scientists, risk-taking executives and activist patients-lend themselves to a gripping insider narrative, the book lacks the details and depth of feeling needed to make that story come alive. Repetition and stilted writing slow the account down further. As a result, the book reads largely as an extended press release for Novartis. Things begin to pick up toward the end, particularly when Vasella defends the high cost of the drug and discusses the challenge of managing patient, media and investor expectations. Gleevec may indeed represent a new direction for cancer research, but the excitement that fact should generate is not captured here. Copyright 2003 Reed Business Information, Inc.

Read more

Review

“Compelling...Vasella reveals the innovative strategies that rushed this orange capsule to desperate patients in record time...a heroic saga.” (Fortune)

Read more

See all Editorial Reviews

Product details

Hardcover: 288 pages

Publisher: HarperBusiness; 1 edition (June 2003)

Language: English

ISBN-10: 9780060010300

ISBN-13: 978-0060010300

ASIN: 0060010304

Product Dimensions:

6 x 0.9 x 9 inches

Shipping Weight: 1.1 pounds (View shipping rates and policies)

Average Customer Review:

3.1 out of 5 stars

13 customer reviews

Amazon Best Sellers Rank:

#1,006,357 in Books (See Top 100 in Books)

What appeared to be a good story on an amazing cancer drug discovery turns out to be a disappointment in reading experience.There is no doubt that the author is intelligent; (given that he did find this amazing drug and remains to be a CEO of a huge pharmaceutical company) but someone should have helped him out with his writing.There were run on sentences, misspelled words and the flow of his writing doesn't get the reader excited. Instead, it conveys a sense of sensationalism and unnecessary drama.

Loved this book - it read like a suspense novel and brought tears to my eyes. Yes it is written from the eyes of big pharma and yes, it is not a cure for all Cancer but it is a dramatic breakthrough and a functional cure for those suffering from a certain type of Leukemia. There are so many lessons to be learned here - the risks and the costs of bringing a drug to market and the many ways that it can never happen - even for ultimately successful drugs like Gleevec.Other readers have rightfully criticized the fact that Gleevec costs $7,000 per month - even more expensive than when it first came on the market in 2001. The medical community has said that there is no basis for this cost and it certainly reeks of price gauging - and this for a drug that you need to take everyday...forever.

While this was a very interesting "inside view" of the pharmaceutical industry, the author (or ghost writer?) tries too hard to sound humanitarian, and ends up sounding rather fake (or as if he were going for a medical school interview). A lot of the book ends up being a justification of the marketing and sales of the drug, and ends up sounding heavy-handed. Also, the reader must be aware that this book does not tell the entire story of Gleevec - just search for it on the NY Times, and the patients will tell you the darker side of the tale. In the end, this book is just another marketing scheme for this niche drug, and should be treated as such.

Book like new. Contained great info on new treatment for my Luekemia CML.

Magic Cancer Bullet: How a Tiny Orange Pill May Rewrite Medical History - do not recommendMagic Cancer Bullet: How a Tiny Orange Pill May Rewrite Medical History - do not recommend

The book title "Cancer's Magic Bullet" is an inaccurate statement so typical of Big Pharma. Does Gleevec work for patients with CML - yes, but there are only about 5,000 new CML patients diagnosed each year with CML versus 10-12,000,000 cancer sufferers overall. Gleevec may be CML's "Magic Bullet", but has no effect on more than 100 other cancers especially solid tumors.How Novartis is cheating all of us - Cancer researchers George Miklos and Phillip Baird masterfully articulate the delusional problem infecting the science of cancer research by showing that cancer researchers, including Novartis, are close to having the worst record for investigational drugs in clinical development. Brian Druker, chair of Leukemia research and professor of medicine at the Oregon Health and Science University Cancer Institute was the key researcher behind the discovery of Gleevec, not Novartis.Druker states, "My work in Oregon on a therapy for CML was primarily funded by public sources, particularly the National Cancer Institute...The approval of Gleevec by the FDA in May 2001 for use in CML was the culmination of a 10-year project for me, something I had dreamed of since medical school."Meanwhile, the price tag for front-line cancer therapy has become obscene. In an essay Druker chastises Novartis for causing him "considerable discomfort" at the price at which Gleevec has been offered for sale by Novartis around the world. This goes against the spirit of the patent system and is not justified given the vital investments made by the public sector over decades that make the discovery of these medicines possible.The Gleevec story should be seen in its proper clinical perspective. There is little point in singing the praises of Gleevec and pretending that it is a proof of principle for solid tumors or some kind of overall "Cancer Magic Bullet" since its use is limited to less than 1% of cancer patients.

This book is both useful--as an insider’s description of how drug development works--and entertaining, as a story of a decidedly unusual case. Gleevec is still in use and seems to be an important part of the drug toolkit, despite the discovery of some side effects. In addition, its discovery does appear to be historic because it was an early example of compounds targeted at particular genetic processes. Dr. Vasella, of course, had personal and corporate reasons for telling this story: he wanted to demonstrate that the company is “people who care,” and he wanted to justify the patenting and pricing of pharma drugs. But he is very explicit about these goals and they don’t detract from the interesting history. I found the style quite readable, although some undefined terms sent me to the Internet and the chronology could have been ordered a bit better.

This is an excellent account of the way things really happen. The media sometimes beats the political drum so loudly about the pharmaceutical industry being an evil empire that the other side of the story is never heard. Here is an inside look from the perspective of dedicated scientists, committed business executives, and the people they serve. If you want to base your opinions on all aspects of the issue, this is required reading.

Magic Cancer Bullet: How a Tiny Orange Pill May Rewrite Medical History PDF
Magic Cancer Bullet: How a Tiny Orange Pill May Rewrite Medical History EPub
Magic Cancer Bullet: How a Tiny Orange Pill May Rewrite Medical History Doc
Magic Cancer Bullet: How a Tiny Orange Pill May Rewrite Medical History iBooks
Magic Cancer Bullet: How a Tiny Orange Pill May Rewrite Medical History rtf
Magic Cancer Bullet: How a Tiny Orange Pill May Rewrite Medical History Mobipocket
Magic Cancer Bullet: How a Tiny Orange Pill May Rewrite Medical History Kindle

Magic Cancer Bullet: How a Tiny Orange Pill May Rewrite Medical History PDF

Magic Cancer Bullet: How a Tiny Orange Pill May Rewrite Medical History PDF

Magic Cancer Bullet: How a Tiny Orange Pill May Rewrite Medical History PDF
Magic Cancer Bullet: How a Tiny Orange Pill May Rewrite Medical History PDF

0 komentar:

Posting Komentar